Company Profile

CellASIC Corporation
Profile last edited on: 3/27/19      CAGE: 475Y2      UEI:

Business Identifier: The CellASIC ONIX Microfluidic Platform is able to measure cell responses to pre-programmed perfusion, temperature, and gas environment changes, all while automated for live cell imaging, giving you the control you need to discover new science.
Year Founded
2004
First Award
2006
Latest Award
2012
Program Status
Inactive
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

2544 Barrington Court
Hayward, CA 94545
   (510) 785-9846
   info@cellasic.com
   www.cellasic.com
Location: Single
Congr. District: 15
County: Alameda

Public Profile

Organized early around the realization that biomedical research would need more tools, as a small firm CellASIC was involved in the develpment microfluidic platforms for cell and tissue based applications. The firm had technology that w/coul enable precise control and large scale analysis of the basic unit of life-- a living cell. Though advances had been made in molecular biology to allow individual genes, protein binding sites, and chemical/biological structures to be identified and targeted, a major technological challenge continued to be investigation how the complex interactions of these individual components result in clinically relevant behaviors. CellASIC addressed this bottleneck by providing precise microfabricated environments to improve the functionality of cell-based experimentation. The firm was initially acquired by Merck and then, in 2012, merged with EMD Millipore Corporation in a cash transaction, CellASIC continues to be a component of that larger firm's offerings in that space.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
1-4
Revenue Range
Less than .5M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
N/A

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2012 2 NIH $905,983
Project Title: Microfluidic Liver Array For Long Term In Vitro Hepatocyte Culture And Screening
2011 2 NIH $896,600
Project Title: Microfluidic Liver Array for Drug Metabolite Profiling
2010 2 NIH $1,002,100
Project Title: Microfluidic System for Automated Cell Toxicity Screening
2009 2 NIH $966,253
Project Title: Microfluidic Bioreactor for High Throughput Cell-based
2007 2 NIH $935,289
Project Title: Continuous Perfusion Cell Microarray for in Vitro Toxicity Screening

Key People / Management

  Philip J Lee

Company News

There are no news available.